Ameriprise
AEHR icon

Ameriprise’s Aehr Test Systems AEHR Stock Holding History

Ameriprise’s Portfolio AEHR Stock Details AEHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-408,401
Closed -$2.98M – 3957
2025
Q1 		$2.98M Sell
408,401
-872,454
-68% -$9.65M ﹤0.01% 2674
2024
Q4 		$21.3M Sell
1,280,855
-6,521
-0.5% -$86.9K 0.01% 1290
2024
Q3 		$16.5M Buy
1,287,376
+902,713
+235% +$13.1M ﹤0.01% 1440
2024
Q2 		$4.3M Sell
384,663
-750,285
-66% -$8.74M ﹤0.01% 2423
2024
Q1 		$14.1M Buy
1,134,948
+176,641
+18% +$2.94M ﹤0.01% 1516
2023
Q4 		$25.4M Buy
958,307
+596,892
+165% +$17.4M 0.01% 1118
2023
Q3 		$16.5M Buy
361,415
+102,144
+39% +$4.74M 0.01% 1347
2023
Q2 		$10.7M Sell
259,271
-1,114,758
-81% -$36.6M ﹤0.01% 1720
2023
Q1 		$42.6M Buy
+1,374,029
New +$44.3M 0.01% 830

Other funds holding AEHR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Ameriprise's AEHR Position: Q2 2025 in Review

Ameriprise sold out of Aehr Test Systems (AEHR) in Q2 2025, closing a stake of 408,401 shares — an estimated $2.98M sold.

Ameriprise first reported a position in AEHR in Q1 2023 and held it in 9 quarters. The position peaked at $42.6M in Q1 2023. 121 funds tracked by Wall St. Rank hold AEHR as of Q2 2025.

  • Ameriprise reported no remaining Aehr Test Systems position as of Q2 2025 after selling out during the quarter.
  • Ameriprise sold 408,401 Aehr Test Systems shares in Q2 2025, an estimated $2.98M.
  • Ameriprise first reported a position in Aehr Test Systems in Q1 2023 and held it in 9 quarters.
  • Ameriprise's Aehr Test Systems position peaked at $42.6M in Q1 2023.
  • 121 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2025.

Based on Ameriprise's 13F filing for Q2 2025, filed 14 Aug 2025.